Travers Smith LLP has advised CGE Partners on its investment in Datapharm, a leading provider of regulatory-driven medicines information and software solutions to the pharmaceutical industry.
Datapharm’s core platform, the electronic medicines compendium (“emc”), is the UK’s leading source of trusted medicines information used by pharmaceutical companies, healthcare professionals and patients. The business supports pharmaceutical companies in maintaining regulatory compliance and its software solutions are trusted by over 300 of the world’s top global life sciences companies.
The Travers Smith team was led by Private Equity & Financial Sponsors Partners Ian Keefe and George Weavil, supported by Senior Associate James Sherlock and Associates Tom Halsey, Jessica Cragg, Nikesh Arya, Rebecca Denton and Tom Morrish. Tax advice was provided by Partner Hannah Manning and Senior Associate Sivanti Devakumar. Commercial, IP & Technology advice was provided by Partner Dan Reavill, Senior Associate Michael Ross and Associates Andy Maxwell, Emma Riggs and Hannah McCullagh. Incentives advice was provided by Senior Counsel Elissavet Grout.
